Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 456

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis

Open access
Borowitz, Drucy, Robinson, Karen A., Rosenfeld, Margaret, Davis, Stephanie D., Sabadosa, Kathryn A., Spear, Stephanie L., Michel, Suzanne H., Parad, Richard B., White, Terry B., Farrell, Philip M., Marshall, Bruce C., Accurso, Frank J.·2009·The Journal of Pediatrics

Abstract

Newborn screening for cystic fibrosis (CF) offers the opportunity for early medical and nutritional intervention that can lead to improved outcomes. Management of the asymptomatic infant diagnosed with CF through newborn screening, prenatal diagnosis, or sibling screening is different from treatment of the symptomatically diagnosed individual. The focus of management is on maintaining health by preventing nutritional and respiratory complications. The CF Foundation convened a committee to develop recommendations based on a systematic review of the evidence and expert opinion. These guidelines encompass monitoring and treatment recommendations for infants diagnosed with CF and are intended to help guide families, primary care providers, and specialty care centers in the care of infants with CF. (J Pediatr 2009;155:S73–93).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpeds.2009.09.001

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Research works printed but not linked: 41

  1. Shepherd, 1989, Total body potassium in cystic fibrosis, J Pediatr Gastroenterol Nutr, 9, 200, 10.1097/00005176-198908000-00012 · doi:10.1097/00005176-198908000-00012
  2. Borowitz, 2005, Update on the evaluation of pancreatic exocrine status in cystic fibrosis, Curr Opin Pulm Med, 11, 524, 10.1097/01.mcp.0000181474.08058.b3 · doi:10.1097/01.mcp.0000181474.08058.b3
  3. Walkowiak, 2005, Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations, J Pediatr Gastroenterol Nutr, 40, 199, 10.1097/00005176-200502000-00022 · doi:10.1097/00005176-200502000-00022
  4. Bellentani, 1984, BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared, Eur J Pediatr, 143, 145, 10.1007/BF00445804 · doi:10.1007/bf00445804
  5. Greer, 1991, Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis, J Pediatr Gastroenterol Nutr, 13, 52, 10.1097/00005176-199107000-00010 · doi:10.1097/00005176-199107000-00010
  6. Durie, 1981, Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction, Pediatr Res, 15, 1351, 10.1203/00006450-198110000-00010 · doi:10.1203/00006450-198110000-00010
  7. Colombo, 1987, The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis, J Pediatr Gastroenterol Nutr, 6, 926, 10.1097/00005176-198711000-00018 · doi:10.1097/00005176-198711000-00018
  8. Remtulla, 1986, Stool chymotrypsin activity measured by a spectrophotometric procedure to identify pancreatic disease in infants, Clin Biochem, 19, 341, 10.1016/S0009-9120(86)80007-8 · doi:10.1016/s0009-9120(86)80007-8
  9. Nissler, 2001, Pancreatic elastase 1 in feces of preterm and term infants, J Pediatr Gastroenterol Nutr, 33, 28, 10.1097/00005176-200107000-00005 · doi:10.1097/00005176-200107000-00005
  10. McClean, 1993, Measurement of fat digestion in early life using a stable isotope breath test, Arch Dis Child, 69, 366, 10.1136/adc.69.3.366 · doi:10.1136/adc.69.3.366
  11. Borowitz, 1995, Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy: consensus committee, J Pediatr, 127, 681, 10.1016/S0022-3476(95)70153-2 · doi:10.1016/s0022-3476(95)70153-2
  12. Schwarzenberg, 1995, Cystic fibrosis-associated colitis and fibrosing colonopathy, J Pediatr, 127, 565, 10.1016/S0022-3476(95)70113-3 · doi:10.1016/s0022-3476(95)70113-3
  13. Holliday, 1991, Growth of human milk-fed and formula-fed infants with cystic fibrosis, J Pediatr, 118, 77, 10.1016/S0022-3476(05)81850-5 · doi:10.1016/s0022-3476(05)81850-5
  14. Ellis, 1998, Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized comparitive trial, J Pediatr, 132, 270, 10.1016/S0022-3476(98)70444-5 · doi:10.1016/s0022-3476(98)70444-5
  15. Canciani, 1985, Absorption of a new semielemental diet in infants with cystic fibrosis, J Pediatr Gastroenterol Nutr, 4, 735, 10.1097/00005176-198510000-00009 · doi:10.1097/00005176-198510000-00009
  16. Rayner, 1989, Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis, Arch Dis Child, 64, 1151, 10.1136/adc.64.8.1151 · doi:10.1136/adc.64.8.1151
  17. Sitrin, 1987, Vitamin E deficiency and neurologic disease in adults with cystic fibrosis, Ann Intern Med, 107, 51, 10.7326/0003-4819-107-1-51 · doi:10.7326/0003-4819-107-1-51
  18. Easley, 1998, Effect of pancreatic enzymes on zinc absorption in cystic fibrosis, J Pediatr Gastroenterol Nutr, 26, 136, 10.1097/00005176-199802000-00003 · doi:10.1097/00005176-199802000-00003
  19. Arvanitakis, 1973, Metabolic alkalosis and salt depletion in cystic fibrosis, J Pediatr, 82, 535, 10.1016/S0022-3476(73)80139-8 · doi:10.1016/s0022-3476(73)80139-8
  20. Laughlin, 1981, Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis, Pediatrics, 68, 203, 10.1542/peds.68.2.203 · doi:10.1542/peds.68.2.203
  21. Ozcelik, 1994, Sodium chloride deficiency in cystic fibrosis patients, Eur J Pediatr, 153, 829, 10.1007/BF01972892 · doi:10.1007/bf01972892
  22. Coates, 2005, Prospective audit of salt supplementation in CF infants, Pediatr Pulmonol Suppl, 28, 345
  23. Steinkamp, 2000, Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients, J Pediatr Gastroenterol Nutr, 31, 418, 10.1097/00005176-200010000-00016 · doi:10.1097/00005176-200010000-00016
  24. Gilljam, 1990, Passive smoking in cystic fibrosis, Respir Med, 84, 289, 10.1016/S0954-6111(08)80055-8 · doi:10.1016/s0954-6111(08)80055-8
  25. Maayan, 1989, Immediate effect of various treatments on lung function in infants with cystic fibrosis, Respiration, 55, 144, 10.1159/000195725 · doi:10.1159/000195725
  26. Button, 2004, Chest physiotherapy, gastro-oesophageal reflux, and arousal in infants with cystic fibrosis, Arch Dis Child, 89, 435, 10.1136/adc.2003.033100 · doi:10.1136/adc.2003.033100
  27. Kosorok, 1998, Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis, Pediatr Pulmonol, 26, 81, 10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K · doi:10.1002/(sici)1099-0496(199808)26:2<81::aid-ppul2>3.0.co;2-k
  28. 2009, Recommended childhood and adolescent immunization schedules–United States, 2009, Pediatrics, 123, 189, 10.1542/peds.2008-3306 · doi:10.1542/peds.2008-3306
  29. Speer, 2008, Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis, Pediatr Infect Dis J, 27, 559, 10.1097/INF.0b013e3181673c15 · doi:10.1097/inf.0b013e3181673c15
  30. Rosenfeld, 1999, Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis, Pediatr Pulmonol, 28, 321, 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V · doi:10.1002/(sici)1099-0496(199911)28:5<321::aid-ppul3>3.0.co;2-v
  31. Harrison, 1985, A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis, Pediatr Pharmacol, 5, 7
  32. Wright, 1970, Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis, Lancet, 1, 9, 10.1016/S0140-6736(70)90523-4 · doi:10.1016/s0140-6736(70)90523-4
  33. Ratjen, 2008, Short and long-term efficacy of inhaled tobramycin in early P. aeruginosa infection: the ELITE study, Pediatr Pulm, 319
  34. Tepper, 1988, Infants with cystic fibrosis: pulmonary function at diagnosis, Pediatr Pulmonol, 5, 15, 10.1002/ppul.1950050105 · doi:10.1002/ppul.1950050105
  35. Villa, 2001, Nocturnal oximetry in infants with cystic fibrosis, Arch Dis Child, 84, 50, 10.1136/adc.84.1.50 · doi:10.1136/adc.84.1.50
  36. Martinez, 2005, High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis, Am J Respir Crit Care Med, 172, 1133, 10.1164/rccm.200412-1665OC · doi:10.1164/rccm.200412-1665oc
  37. Lynch, 1990, Pediatric pulmonary disease: assessment with high-resolution ultrafast CT, Radiology, 176, 243, 10.1148/radiology.176.1.2353097 · doi:10.1148/radiology.176.1.2353097
  38. Turner, 1994, Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis, Eur Respir J, 7, 1995, 10.1183/09031936.94.07111995 · doi:10.1183/09031936.94.07111995
  39. Kraemer, 1989, Early detection of lung function abnormalities in infants with cystic fibrosis, J R Soc Med, 82, 21
  40. Beardsmore, 1988, Lung function in infants with cystic fibrosis, Thorax, 43, 545, 10.1136/thx.43.7.545 · doi:10.1136/thx.43.7.545
  41. Godfrey, 1978, Serial lung function studies in cystic fibrosis in the first 5 years of life, Arch Dis Child, 53, 83, 10.1136/adc.53.1.83 · doi:10.1136/adc.53.1.83

Cited by

See all 456

Metadata

Authors
Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., Marshall, B. C., & Accurso, F. J.
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
2009-12
Volume
155
Issue
6
Pages
S73-S93
ISSN
0022-3476 (ISSN-L)
OpenAlex
W2104682204
Cited by
456
References
109
FWCI
15.50
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. https://app.cochat.ai/papers/10.1016/j.jpeds.2009.09.001
The paper
Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., Marshall, B. C., & Accurso, F. J. (2009). Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. The Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2009.09.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.